Traumatic brain injury (TBI) causes significant mortality, long term disability
and psychological symptoms. Gene therapy is a promising approach for treatment of
different pathological conditions. Here we tested chitosan and polyethyleneimine
(PEI)-coated magnetic micelles (CPmag micelles or CPMMs), a potential MRI contrast agent,
to deliver a reporter DNA to the brain after mild TBI (mTBI). CPMM - tomato plasmid (ptd)
conjugate expressing a red-fluorescent protein (RFP) was administered intranasally
immediately after mTBI or sham surgery in male SD rats. Evans blue extravasation following
mTBI suggested CPMM-ptd entry into the brain via the compromised blood-brain barrier.
Magnetofection increased the concentration of CPMMs in the brain. RFP expression was
observed in the brain (cortex and hippocampus), lung and liver 48 hours after mTBI. CPMM
did not evoke any inflammatory response by themselves and were excreted from the body.
These results indicate the possibility of using intranasally administered CPMM as a
theranostic vehicle for mTBI.